SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : QLT PhotoTherapeutics (QLTI) -- Ignore unavailable to you. Want to Upgrade?

To: Edward W. Richmond who wrote (1059)10/10/2000 1:28:18 PM
From: BostonView  Read Replies (3) | Respond to of 1321
 
Thanks, Edward. One question, for clarification:

On point two, "QLT has received no information about disappointing results from retinologists using Visudyne."

Does this mean they've asked, or put another way, are in regular contact with this group? Or merely don't have any feedback data?

It's splitting hairs, but an important distinction, IMO.

BV


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News